Analysts Viewpoint
Checking in on BridgeBio Pharma Inc (BBIO) after recent insiders movement
In a filing, BridgeBio Pharma Inc revealed its Director MCCORMICK FRANK unloaded Company’s shares for reported $3.93 million on Sep
Menu
In a filing, BridgeBio Pharma Inc revealed its Director MCCORMICK FRANK unloaded Company’s shares for reported $3.93 million on Sep
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BridgeBio Pharma
BridgeBio Pharma Inc’s filing revealed that its Director MCCORMICK FRANK unloaded Company’s shares for reported $3.93 million on Sep 05
In a filing, BridgeBio Pharma Inc revealed its Director MCCORMICK FRANK unloaded Company’s shares for reported $3.93 million on Sep
In a filing, BridgeBio Pharma Inc revealed its Director FRANK P. MCCORMICK acquired Company’s shares for reported $3.93 million on
BridgeBio Pharma Inc’s recent filing unveils that its President and CFO Trimarchi Thomas unloaded Company’s shares for reported $2.09 million
BridgeBio Pharma Inc’s recent filing unveils that its President and CFO Trimarchi Thomas unloaded Company’s shares for reported $2.09 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
BridgeBio Pharma Inc’s filing revealed that its Director HOMCY CHARLES J unloaded Company’s shares for reported $11.51 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or